Acute ischaemic stroke: part II. The vertebrobasilar circulation.

OBJECTIVE To review recent advances in the management of acute ischaemic stroke in a two part presentation. DATA SOURCES Articles and a review of studies reported from 1990 to 2000 and identified through a MEDLINE search of the English language literature on acute ischaemic stroke. SUMMARY OF REVIEW An acute ischaemic stroke of the vertebrobasilar circulation is investigated initially with a cerebral computed tomography scan largely to differentiate it from a haemorrhagic stroke. However, cerebral magnetic resonance imaging identifies the ischaemic brainstem lesions more accurately and is often performed with MR angiography to determine the site and extent of the ischaemic vertebrobasilar lesion. Treatment with aspirin (150-300 mg) within the first 48 hr as well as management in a specialised unit focusing on resuscitation and prevention of complications has reduced morbidity and mortality. While therapy to improve cerebral blood flow or agents to reduce further neuronal damage have not produced consistent improvement in outcome, numerous small studies using intravenous or intraarterial thrombolytics, percutaneous transluminal angioplasty or stents have reported improved outcome in selected cases. CONCLUSIONS An acute ischaemic stroke in the distribution of the vertebrobasilar circulation requires aspirin 150-300 mg daily and management in an acute stroke unit. Intra-arterial or intravenous thrombolytic therapy and percutaneous transluminal angioplasty or stents to improve cerebral blood flow (even up to 24 hours after the event) have been reported to be beneficial in selected cases.

[1]  G. Famularo The puzzle of neuronal death and life: is mannitol the right drug for the treatment of brain oedema associated with ischaemic stroke? , 1999, European journal of emergency medicine : official journal of the European Society for Emergency Medicine.

[2]  M. Bousser Aspirin or heparin immediately after a stroke? , 1997, The Lancet.

[3]  P. Bath Alteplase not yet proven for acute ischaemic stroke , 1998, The Lancet.

[4]  W. Heiss,et al.  Early intravenous thrombolysis with recombinant tissue-type plasminogen activator in vertebrobasilar ischemic stroke. , 1998, Archives of neurology.

[5]  R. Higashida,et al.  Transluminal angioplasty for arteriosclerotic disease of the distal vertebral and basilar arteries. , 1996, Journal of neurology, neurosurgery, and psychiatry.

[6]  D. Dunbabin Reperfusion therapy for stroke. , 1999, Australian and New Zealand journal of medicine.

[7]  G. Donnan Investigation of patients with stroke and transient ischaemic attacks , 1992, The Lancet.

[8]  A M Malek,et al.  Treatment of posterior circulation ischemia with extracranial percutaneous balloon angioplasty and stent placement. , 1999, Stroke.

[9]  Langhorne,et al.  Collaborative systematic review of the randomised trials of organised inpatient (stroke unit) care after stroke , 1997, BMJ.

[10]  W. Hacke,et al.  Vertebrobasilar thrombosis: diagnosis, management, and the use of intra-arterial thrombolytics. , 1996, Critical care medicine.

[11]  L. Worthley,et al.  Induced and accidental hypothermia. , 2000, Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine.

[12]  H. J. Gelmers,et al.  A controlled trial of nimodipine in acute ischemic stroke. , 1988, The New England journal of medicine.

[13]  J. Ulatowski,et al.  Intraarterial thrombolysis in vertebrobasilar occlusion. , 1996, AJNR. American journal of neuroradiology.

[14]  Gregory,et al.  Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease. , 1988, Stroke.

[15]  M. Kaste,et al.  [Thrombolytic therapy of basilar artery occlusion]. , 1998, Duodecim; laaketieteellinen aikakauskirja.

[16]  J. Hirsh,et al.  Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. , 1998, Chest.

[17]  T. Osborn,et al.  Intravenous thrombolytic therapy for stroke: a review of recent studies and controversies. , 1999, Annals of emergency medicine.

[18]  T. Itakura,et al.  Percutaneous Transluminal Angioplasty for Intracranial Arteriosclerotic Lesions , 1997, Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences.

[19]  P. Black,et al.  External pneumatic calf compression reduces deep venous thrombosis in patients with ruptured intracranial aneurysms. , 1986, Neurosurgery.

[20]  K. Uemura,et al.  Thrombolysis and angioplasty for acute occlusion of intracranial vertebrobasilar arteries. Report of three cases. , 1998, Journal of neurosurgery.

[21]  S. Slørdahl,et al.  Stroke unit treatment. Long-term effects. , 1997, Stroke.

[22]  M. Diringer,et al.  Relationship between clot location and outcome after basilar artery thrombolysis. , 1997, AJNR. American journal of neuroradiology.

[23]  L. Kiers,et al.  Cardiogenic brain embolism: role of anticoagulants. , 1989, Australian and New Zealand journal of medicine.

[24]  E. Wijdicks,et al.  Intra-arterial thrombolysis for vertebrobasilar circulation ischemia. , 1999, Critical care clinics.

[25]  G. Hankey 1: Transient ischaemic attacks and stroke , 2000, The Medical journal of Australia.

[26]  D. Moliterno,et al.  Basilar artery rethrombosis: successful treatment with platelet glycoprotein IIB/IIIA receptor inhibitor. , 1997, AJNR. American journal of neuroradiology.

[27]  T. Murphy,et al.  Acute vertebrobasilar occlusion: treatment with high-dose intraarterial urokinase. , 1999, AJR. American journal of roentgenology.

[28]  T. Price,et al.  Cooperative study of hospital frequency and character of transient ischemic attacks. I. Background, organization, and clinical survey. , 1977, JAMA.

[29]  R. Higashida,et al.  Endovascular stenting of an acutely thrombosed basilar artery: technical case report and review of the literature. , 1999, Neurosurgery.

[30]  J. Evans,et al.  Pressure ulcers: prevention and management. , 1995, Mayo Clinic proceedings.

[31]  M. Brainin,et al.  Hypervolemic hemodilution in acute ischemic stroke: the Multicenter Austrian Hemodilution Stroke Trial (MAHST). , 1998, Stroke.

[32]  T. N. t-P. S. S. Group Randomised, double-blind, placebo-controlled trial of nimodipine in acute stroke , 1990, The Lancet.

[33]  A. Turpie,et al.  Intravenous heparin for the prevention of stroke progression in acute partial stable stroke. , 1986, Annals of internal medicine.

[34]  R. Newcombe,et al.  DOUBLE-BLIND RANDOMISED TRIAL OF INTRAVENOUS GLYCEROL IN ACUTE STROKE , 1987, The Lancet.

[35]  K. Shine,et al.  Is cardiac ultrasound mandatory in patients with transient ischaemic attacks? , 1985, British medical journal.

[36]  N. Bornstein,et al.  SUBCLAVIAN STEAL: A HARMLESS HAEMODYNAMIC PHENOMENON? , 1986, The Lancet.